Orbital metastasis

Orbital metastases are relatively uncommon, but some primary tumours do have a predilection to metastasise to the orbit.

This article concerns itself with extraocular metastases, rather than intraocular tumours or direct extension of tumours from neighbouring regions. For a discussion of intraocular metastases please refer to uveal metastases.

Extraocular orbital metastases are uncommon, accounting for 2-11% of all orbital neoplasms, and significantly less common than uveal metastases, which outnumber orbital metastases by 8 to 1 1,3,6. The demographics of affected patients reflect the demographics of the primary tumours (see below). 

In general, patients with metastatic disease do not develop orbital metastases, being identified clinically in <1% of cases. Prevalence is much higher in autopsy series, reflecting the high prevalence of asymptomatic orbital deposits 7.

In ~40% of patients who are symptomatic from orbital metastases (except for breast cancer metastases), orbital symptoms occur well before local symptoms from the primary tumour manifest, and as such is the first indication of advanced malignancy 1,3,6

Unlike primary orbital tumours which most frequently present with proptosis and/or visual loss, orbital metastases most commonly present with diplopia 1. Pain is also frequently present. 

Enophthalmos due to infiltration and desmoplasia is most frequently encountered with breast carcinoma metastases, although it may also be occasionally seen in metastases from gastrointestinal tract adenocarcinoma 4. This may be associated with hypoglobus.

Diagnosis is often known and widespread metastatic disease offers easier targets for biopsy. In cases where orbital metastases are isolated, a biopsy may be required to establish the diagnosis. This is usually performed as an open biopsy, to allow for adequate haemostasis 1,3.

Common tumours to metastasize to the orbit include 1-6

In contrast to uveal metastases which can be bilateral (up to 25%), extraocular orbital metastases are usually unilateral (with the exception of neuroblastoma) 7, and only infrequently primarily involve the extraocular muscles (with the exception of melanoma) 7, although secondary involvement as the metastasis grows is common 1,2. Thyroid and prostate metastases are frequently located in the bony margins of the orbit 7.

The superior lateral extraconal quadrant is most frequently involved although all parts of the orbit may be the site of metastatic deposit.

CT appearances are variable. In most instances, soft tissue attenuating material is identified, located in the extraconal compartment 6. The morphology is variable, ranging from well-defined rounded lesions to diffusely infiltrating lesions 5.

In general, enhancement is present. Bony destruction may also sometimes be seen, and careful assessment of the remainder of the scan essential in identifying additional deposits.

MRI appearances are similar to CT, but the greater contrast resolution of MRI makes it invaluable in the assessment of orbital masses.

Fat-suppressed T2 and post-contrast T1 weighted images, with thin slice thickness and a reduced FOV is ideal and should include the cavernous sinuses.

  • T1: isointense to muscle 8
  • T2: hyperintense to muscle, hypointense to fat
  • T1 C+ (Gd): enhancement present but variable

Treatment is primarily with radiotherapy, typically with a total dose of 30-40 Gy 1. Depending on the tumour histology chemotherapy may also be useful. Surgery is usually limited to patients with isolated orbital involvement without an identifiable (or a previously treated) primary.

Unfortunately, the discovery of orbital metastases usually indicates advanced and widespread metastatic disease and prognosis are dismal with the majority of patients succumbing to their illness within a year (average time from diagnosis to death is 4 months) 7.

Share article

Article information

rID: 9669
Synonyms or Alternate Spellings:
  • Orbital metastases
  • Extraocular orbital metastases
  • Extraocular orbital metastasis

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Case 1: from breast cancer
    Drag here to reorder.
  • Drag
    Case 2: from breast cancer
    Drag here to reorder.
  • Drag
    Case 3: from malignant melanoma
    Drag here to reorder.
  • Drag
    Case 4: from breast cancer
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.